Skip to main content

Peer Review reports

From: Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study

Original Submission
27 Jan 2023 Submitted Original manuscript
25 May 2023 Reviewed Reviewer Report
6 Jun 2023 Reviewed Reviewer Report
20 Aug 2023 Author responded Author comments - Katsuhiko Nara
23 Aug 2023 Author responded Author comments - Katsuhiko Nara
Resubmission - Version 2
20 Aug 2023 Submitted Manuscript version 2
25 Aug 2023 Author responded Author comments - Katsuhiko Nara
Resubmission - Version 3
25 Aug 2023 Submitted Manuscript version 3
9 Sep 2023 Reviewed Reviewer Report
24 Sep 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Oct 2023 Editorially accepted
13 Oct 2023 Article published 10.1186/s12885-023-11469-y

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us